Monitoring of endothelial activation markers during physiological pregnancy


Authors: J. Procházková 1;  I. Dhaifallah 2;  A. Měchurová 3;  R. Pilka 2;  O. Šimetka 4;  L. Slavík 1;  J. Úlehlová 1;  M. Lubušký 2;  M. Procházka 2
Authors‘ workplace: Hemato-onkologická klinika FN a LF UP, Olomouc, přednosta prof. MUDr. K. Indrák, DrSc. 1;  Porodnicko-gynekologická klinika FN a LF UP, Olomouc, přednosta doc. MUDr. R. Pilka, Ph. D. 2;  Ústav pro péči o matku a dítě, Praha, ředitel doc. MUDr. J. Feyereisl, CSc. 3;  Porodnicko-gynekologická klinika FN, Ostrava, přednosta MUDr. O. Šimetka 4
Published in: Ceska Gynekol 2010; 75(2): 92-100

Overview

Aim of the study:
To establish endothelial activation markers which could uncover endothelial damage during physiological pregnancy.

Type of study:
Prospective study.

Method:
We examined 403 pregnant women with a physiological pregnancy. Venous blood samples were collected from the women at the beginning of the pregnancy, a second sample was collected in the interval 24-28 weeks gestation. Parameters were examined using methods: t-PA – ELISA, PAI-1 – ELISA, vWF Ag – EIA ePCR – ELISA, MMP-2,9 – ELISA with fluorogenic detection, TIMP-2 – ELISA, endothelial microparticles - flow cytometry.

Results:
The level of vWF antigen increased during the entire course of pregnancy (in the I. trimester the average level was 152,32%, in the II. and III. trimester 173.34% and 216.20% respectively). At the same time, vWf activity also increased (I. trimester average level 130.20%, II. and III. trimester 150.09% and 181.91% respectively). The level of thrombomodulin significantly increased during pregnancy (I. trimester average level 19,05 ng/ml, II. and III. trimester 28,47 ng/ml and 39,86 ng/ml respectively). The level of soluble form of EPCR increased during pregnancy (I. trimester average level 201.76 ng/ml, II. and III. trimester 274.68 ng/ml and 324.07 ng/ml respectively). The level of PAI–1 increased during the entire course of pregnancy (I. trimester average level 36.14 ng/ml, II. and III. trimester 50.07 ng/ml and 60.12 ng/ml respectively). The level of t- PA did not change significantly during the course of pregnancy (I. trimester average level 2.48 ng/ml, II. and III. trimester 2.97 and 3,34 ng/ml respectively). The levels of MMP-2 (I. trimester average level 9043,76 RFU, II. and III. trimester 9315.38 and 8800.27 RFU respectively), MMP-9 (I. trimester average level 8371.90, II. and III. trimester 8290.81 and 7470.50 respectively), TIMP-2 (I. trimester average level 92.5 ng/ml, II. and III. trimester 98.5 and 96.5 ng/ml respectively) or endothelial microparticles (I. trimester average level 3838.38 particles/μl, II. and III. trimester 3836.59 and 3650.59 particles/μl respectively) did not change significantly throughout the individual trimesters.

Conclusion:
We confirmed the hypothesis regarding the significant influence pregnancy has on changes in levels of these markers.

Key words:
endothelium, pregnancy, activation, preeclampsia.


Sources

1. Blann, AD. Assessment of endothelial dysfunction: focus on atherothrombotic disease. Pathophysiol Haemostasis Thrombosis 2005, 34.

2. De Caterina, R., Libby, P. Endothelial dysfunctions and vascular disease. Viley and sons: Blackwell Publishing, 2007, p. 3-25.

3. Hoffbrand, AV., Catovsky, D., Tuddenham, EGD. Postgraduate Hematology. Viley and sons: Blackwell Publishing, 2005, p. 787-792.

4. Kvasnička, J. Trombofilie a trombotické stavy v klinické praxi. Praha: Grada Publishing, 2003, s. 40-65.

5. Pecka, M. Laboratorní hematologie v přehledu. Fyziologie a patofyziologie hemostázy. 2004, s. 22-24, 87-97, 113-118.

6. Pilka, R., Hrachovec, P. Matrix metaloproteinázy a menstruace. Čes Gynek 2003, 68, s. 36-40.

7. Šimetka, O., Brychtová, P., Procházková, J., Procházka, M. Laboratorní změny aktivace endotelu u syndromu HELLP. Gynekolog 2008, 2, s. 48-53.

8. Holmes, VA., Wallace, JMW. Haemostasis in normal pregnancy: a balancing act? Biochemical Society Transactions 2005, 33, part 2, p. 428-432.

9. Brenner, B. Haemostatic changes in pregnancy. Thromb Res 2004, 114, p. 409-414.

10. Buffa, MC., Valsecchi, L., Fausto, A. Predictive value of plasma thrombomodulin in preeclampsia and gestational hypertension. Tromb Haemost 1998, 79, p. 1092-1095.

11. Stirling, Y., Woolf, L., North, WR., et al. Haemostasis in normal pregnancy. Thromb Haemost 1984, 52, p. 176-182.

12. Ishii, A., Yamada, R., Hamada, H. t-PA activity in peripheral blond obtained from pregnant women. J Perinat Med 1994, 22, p. 113-117.

13. Bremme, K., Ostlund, E., Almquist, I. Enhanced thrombin generation and fibrinolytic activity in the normal pregnancy and the puerperium. Obstet Gynecol 1992, 80, p. 132-137.

14. Bretelle, F., Sabatier, F., Desprez, D., et al. Circulating microparticles: a marker of procoagulant state in normal pregnancy complicated by preeclamsia or intrauterine growth restriction. Thromb Haemost 2003, 89, p. 486-492.

15. VanWijk, MJ., Svedas, E., Boer, K., et al. Isolated microparticles, but not whole plasma, from women with preeclampsia impair endothelium-dependent relaxation in isolated myometrial arteries from healthy pregnant women. Am J Obstet Gynecol 2002, 187, p. 1686-1693.

16. Raffaetto, JD., Khalil, RA. Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease. Biochem Pharmacol 2008, 75(2), p.346-59. Epub 2007 Jul 7. Review.

Labels
Paediatric gynaecology Gynaecology and obstetrics Reproduction medicine

Article was published in

Czech Gynaecology

Issue 2

2010 Issue 2

Most read in this issue
Login
Forgotten password

Don‘t have an account?  Create new account

Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account